ADVANCE · 105MS301
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy and safety of pegylated interferon beta-1a (BIIB017) in participants with relapsing multiple sclerosis. EudraCT: 2008-006333-27.
Sponsor: BIOGEN
Phase: III
Area: Neuroimmunology